Wie is wie INfusie VErsus STimulatie

Rob de Bie Hospital Patient Monitoring Manager BeNeLux Philips LinkedIn

Until more effective methods of providing stable dopamine concentrations are developed, current evidence supports the use of levodopa as initial symptomatic treatment in most patients with Parkinson's disease, starting with low doses and titrating to therapeutic threshold.

two men standing next to each other in front of a train on the tracks and buildings

Cochrane Musculoskeletal group, Ottawa (p. Tugwell), Cochrane Back Group, Toronto (L. Bouter, C. Bombardier), Folkehelse, National institute for public health (K.

Rob de Bie, hoogleraar Neurologische Bewegingsstoornissen Universiteit van Amsterdam

Rob de Bie received financial support for a fellowship program from Medtronic, and has received research grants from ZonMw, Internationaal Parkinson Fonds, Prinses Beatrix Fonds, Michael J Fox Foundation, and Parkinson Vereniging. Günther Deuschl has received lecture fees from Orion, Lundbeck, Teva and Pfizer and has been serving as a.

AMLnZu68HAg6WOdHloGSOPE3NkBHQ1i5pMYYr7Y8QWE=s900ckc0x00ffffffnorj

De Bie has worked as a neurologist at the AMC since 2006. In 2005 and 2006, he took a clinical fellowship in movement disorders at Toronto Western Hospital in Canada. He leads the movement disorders group at the AMC and the Neurodegeneration programme at the Netherlands Institute for Neuroscience in Amsterdam.

Rob de Bie (RobAdeBie) Twitter

Rob M A de Bie Academisch Medisch Centrum Universiteit van Amsterdam | AMC · Department of Neurology MD, PhD Connect with experts in your field Join ResearchGate to contact this researcher.

Wie is wie INfusie VErsus STimulatie

Rob de Bie Prof. PhD Full Professor, ANS - Neurodegeneration Full Professor, APH - Aging & Later Life Full Professor, Neurology PI 1997 2023 Specialization Neurology, Movement Disorders Focus of research Improving treatment of Movement Disorders.

Rob Snijders Senior Advisor Antilope De Bie printing LinkedIn

Professor of Movement Disorders Rob de Bie of Amsterdam Neuroscience works at Amsterdam UMC where he meets people with Parkinson's on a daily basis. De Bie is one of the main neurologists focusing on Parkinson's disease. "I'm driven by my daily experiences with people suffering from this disease", says de Bie.

AL5GRJXTy3XnyKqU3GwkFM3wRCkzwPKwqkmlUIHs71JY=s900ckc0x00ffffffnorj

Rob de Bie is a neurologist and works at the Academic Medical Center in Amsterdam. In 2005-06, he did a Movement Disorders Fellowship with Prof Tony Lang in Toronto. His research focuses on the treatment of Parkinson's disease, including the current NSTAPS study.

Rob de Bie's question about the construction at Volkel Aircraft WWII

Study design: A systematic review of randomized controlled trials. Objectives: To evaluate the effectiveness of segmental stabilizing exercises for acute, subacute and chronic low back pain with regard to pain, recurrence of pain, disability and return to work.

Parkinson Geef aan onderzoek naar behandeling op maat ProPark (BS051) LUMC Campagne

Paul Willems 1 , Rob de Bie, Cumhur Oner, René Castelein, Marinus de Kleuver. Affiliation 1 Department of Orthopaedics, Research School Caphri, Maastricht University Medical Center, Maastricht, the Netherlands. PMID: 22189352 PMCID: PMC3278483 DOI: 10.1136/bmjopen-2011.

Anticiperen of acuut reageren de toekomst van intensive care Philips

a RoB 2.0: D1, randomization process; D2, deviations from the intended interventions; D3, missing outcome data; D4. analysis, and writing of the draft. At the end, they took care of the visualization of the manuscript. Dr Lenssen, Dr de Bie, Dr Scherr, and Dr Swanenburg were involved in reviewing and editing the writing part of the.

Rob de Leeuw Perfon

Rob de Bie focust zich vooral op het verbeteren van de behandeling van Parkinson. Hieronder valt de behandeling met diepe hersenstimulatie, die in het AMC ook bij mensen met andere bewegingsstoornissen wordt toegepast. De Bie heeft diverse grote klinische onderzoeken geïnitieerd en geleid die hebben bijgedragen aan de verbetering van de.

Physio 15 Poor funding for physio research hampers attempts to build evidence base The

Rob A de Bie currently works at the CAPHRI School for Public Health and Primary Care, Maastricht University. Rob does research in Musculoskeletal Disorders, etiology, prognosis and impact of.

Karakteristieken voetbal regio Deventer / Zutphen Foto destentor.nl

Rob A de Bie currently works at the CAPHRI School for Public Health and Primary Care, Maastricht University. Rob does research in Musculoskeletal Disorders, etiology, prognosis and impact of.

Rob de Bie

Rob De Bie (Principal Investigator), Prof. PhD Full Professor, Neurology (AMC) Full Professor, Amsterdam Neuroscience - Neurodegeneration (AMC) Full Professor, APH - Aging & Later Life (AMC) https://orcid.org/0000-0001-5267-0784 1997. 2023 Research activity per year Overview Network Projects (3) Research output (212) Prizes (1) Supervised Work (3)

Rob de Bie LinkedIn

Rob de Bie studied physiotherapy (graduated 1987, Deventer), human movement sciences (graduated in 1991, Maastricht University) and epidemiology (registered in 1992), obtained his PhD in 1998 and has been Associate Professor in Clinical Epidemiology at Maastricht University, the Netherlands from 1999 -2003.